Collecting real-world data on cancer patients treated with radiotherapy in Europe

E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe

Observational European Organisation for Research and Treatment of Cancer - EORTC · NCT03818503

This study is collecting information from cancer patients receiving radiotherapy in Europe to see how well this treatment works alongside other therapies.

Quick facts

Study typeObservational
Enrollment2000 (estimated)
Ages12 Years and up
SexAll
SponsorEuropean Organisation for Research and Treatment of Cancer - EORTC Research network
Drugs / interventionsradiation
Locations77 sites (Graz and 76 other locations)
Trial IDNCT03818503 on ClinicalTrials.gov

What this trial studies

This observational study aims to gather real-world data from cancer patients who are undergoing radiotherapy. It focuses on understanding the role of radiation oncology within a multidisciplinary treatment approach. The study is non-interventional and will include multiple cohorts of patients, ensuring a comprehensive analysis of treatment outcomes. Participants will be monitored over time to provide valuable insights into the effectiveness of radiotherapy in cancer care.

Who should consider this trial

Good fit: Ideal candidates include patients aged 12 years and older with pathologically confirmed cancer who are planned to receive radiotherapy.

Not a fit: Patients who do not have a confirmed cancer diagnosis or are not planned for radiotherapy will not benefit from this study.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of radiotherapy's impact on cancer treatment and improve patient outcomes.

How similar studies have performed: Other studies collecting real-world data in oncology have shown success in improving treatment protocols and patient outcomes, indicating that this approach is promising.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pathologically confirmed cancer.
* Written informed consent for E²-RADIatE according to applicable legal and ethical requirements
* Planned use of radiotherapy
* Eligibility of the patient confirmed for at least one cohort confirmed
* Patients of 12 years and older

Where this trial is running

Graz and 76 other locations

+27 more sites — see ClinicalTrials.gov for the full list.

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Cancer
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.